Background: A variety of rheumatic diseases can significantly affect the patient's quality of life and work ability. SF-36 is a commonly used tool to assess the quality of life and work ability in patients with chronic disease. In the past, most patients were guided by doctors/nurses to assess SF-36 in a paper form. At present, there is a lack of research on the quality of life in patients with rheumatic diseases by using new mobile tools in the real world. Objectives: To explore the effect to the life ability of rheumatic disease and the potential association between the disease activity and SF-36 in patients with rheumatoid arthritis (RA) using SSDM. Methods: SSDM is a new smart disease management mobile tool, which includes physicians' and patients' application system. After entering the results of SF-36 assessment by patients, all data can be synchronized automatically to the mobile terminal of authorized rheumatologist. According to the scores of SF-36 (<12.5, 12.5-50 and >50), the quality of life was divided into three levels: poor, moderate and good. Results: From June 2016 January 2017, data were extracted online from the mobile terminals of 839 adult patients (284 male and 555 female) in 62 hospitals across China. All patients performed self-assessment of SF-36 for a total of 1,065 times. The mean age was 38.12±13.87 (18 to 81) years and the median disease duration was 20.60 (0 to 573) months. There are 25 kinds of rheumatic diseases involved, including RA (23%), ankylosing spondylitis (AS, 19%), systemic lupus erythematosus (SLE, 13%), osteoarthritis (OA, 11%), Sjogren syndrome (SS, 10%), polymyositis/dermatomyositis (PM/DM, 6%), mixed connective tissue disease (MCTD, 6%) and others (12%). The 8 items of SF-36 index were averaged between 49.07 (General Health perceptions, GH) to 74.12 (Physical Functioning, PF). The overall mean score of patients with different rheumatic diseases was higher than 50. However, there were 5 kinds of rheumatic diseases with average score of 5 items less than 50, including: MCTD, SS, PM/DM, AS and SLE in patients with GH score: 44.24, 44.60, 47.87, 47.93 and 49.16 Background: The applicability of ultrasonography in diagnosis and monitoring of rheumatic diseases has been steadily growing but little is known about the patient's perspective. Objectives: To assess the patient's knowledge of the ultrasound (US) method and its clinical applicability as well as to evaluate how much was learned after a lecture. Methods: Patients with rheumatic diseases were invited to an educational meeting that included an US lecture. They were asked to fill out a questionnaire before and after the 35-minute lecture about US and its clinical uses. The questionnaire included questions about their disease and treatment, their educational background (years of study) and ten questions about US and its clinical uses (table).These ten questions had to be answered with "yes", "no", or "I am not sure". Results: A total of 70 patients attended the lecture and answered the questionnaires. Their demographic characteristics were as follows: Mean ± SD: age 63±12 years, disease duration: 9.6±0.8 years, the most frequent self-reported diagnosis was rheumatoid arthritis (57,2%), while osteoarthritis accounted for another 20%. Most patients had only eight years of study (64.3%) and a university degree was reported by 14%. The questionnaire responses of 66 patients with rheumatic diseases were analysed. There was a noticeable increase in the positive responses to these questions: 1, 2, 3 and 7, after the lecture, 44% (p=0.001); 29% (p=0.001); 10% (p=0.06); 27% (p=0.009), respectively. Although only 26% of the patients have had an articular US, in 65% it led to a change in treatment. Positive answers to some questions, which were perhaps too complex, showed a discrete increase, less than 10%, conceivably due to the surprisingly high background of positive answers. Conclusions: As expected, the US image method was familiar to most but not its applicability in articular diseases. After the lecture there was an increase in understanding of the positive impact of US in rheumatic diseases, implying that short and focused lectures are a useful tool in educational programs for patients. Background: Fatigue, sleep disturbances and pain, are symptoms of primary Sjögren's syndrome (PSS). However, current clinical interventions predominantly focus on treating patients' dryness symptoms. Objectives: To explore the experience of fatigue, sleep disturbances and discomfort in people with PSS, to investigate the impact of these symptoms on patients' daily lives and to develop an intervention strategy to address them. Methods: Qualitative focus groups with open-ended questions allowed participants to explore ideas together and focus on issues they perceived as being important. PSS patients (n=10) and spouses (n=3) took part in three focus groups divided into six sessions which were facilitated by two clinician researchers using a topic guide. Discussion topics included; the symptoms, strategies used by patients used to manage their symptoms, possible future intervention components proposed from the literature and possible modes of delivering future interventions. The meetings were audio-recorded, transcribed verbatim and analysed using thematic analysis 1 . Results: Patient participants all experienced these symptoms. Symptom severity varied within individuals and flares occurred unpredictably. Fatigue, sleep disturbances and discomfort, all affected patients' lives and those around them and sometimes felt overwhelming. Discomfort symptoms included oral and ocular dryness, tingling, nausea and difficulties tolerating light and noise. The invisible nature of these features meant patients often struggled to meet others' expectations, which affected their mood and resulted in social withdrawal. Fatigue was a major barrier to engaging in work, productivity and leisure activities. Sleep disturbances further compounded the fatigue. Patients employed a range of strategies to self-manage their symptoms to varying degrees of success. Participants expressed a need for tailored support from health care professionals which included information provision, access to peer support and professional support to apply symptom management information. A three stepped model of care was proposed. The model includes different modes of delivering intervention content, including written information, education groups, peer support, digital self-management and one-to-one therapy. Intervention intensity increased with each step in the model. Numbers are n (%),
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Conclusions:
The majority of JIA patients and controls participated in organized or unorganized PA. Fun was the most reported facilitator in patients, followed by becoming fit and having less pain. Pain was the dominant PA barrier in patients, while time was the most frequently reported barrier in controls. Some patients experienced disease activity as a barrier. Nearly all the patients (97%) participated regularly in PE, but 1 /4 needed some modifications. These results are reassuring, and highlight the importance of enjoyment for participation in PA. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.6063
